These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27634008)

  • 1. Chronic Kappa opioid receptor activation modulates NR2B: Implication in treatment resistant depression.
    Dogra S; Kumar A; Umrao D; Sahasrabuddhe AA; Yadav PN
    Sci Rep; 2016 Sep; 6():33401. PubMed ID: 27634008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria.
    Bruchas MR; Land BB; Aita M; Xu M; Barot SK; Li S; Chavkin C
    J Neurosci; 2007 Oct; 27(43):11614-23. PubMed ID: 17959804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.
    Morgenweck J; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():600-9. PubMed ID: 26318102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
    Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
    J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting kappa opioid antagonists disrupt receptor signaling and produce noncompetitive effects by activating c-Jun N-terminal kinase.
    Bruchas MR; Yang T; Schreiber S; Defino M; Kwan SC; Li S; Chavkin C
    J Biol Chem; 2007 Oct; 282(41):29803-11. PubMed ID: 17702750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient activation of the CA3 Kappa opioid system in the dorsal hippocampus modulates complex memory processing in mice.
    Daumas S; Betourne A; Halley H; Wolfer DP; Lipp HP; Lassalle JM; Francés B
    Neurobiol Learn Mem; 2007 Jul; 88(1):94-103. PubMed ID: 17374494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the psychotomimetic benzomorphan N-allylnormetazocine (SKF 10,047) on prepulse inhibition of startle in mice.
    Halberstadt AL; Hyun J; Ruderman MA; Powell SB
    Pharmacol Biochem Behav; 2016 Sep; 148():69-75. PubMed ID: 27236030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance.
    McLaughlin JP; Myers LC; Zarek PE; Caron MG; Lefkowitz RJ; Czyzyk TA; Pintar JE; Chavkin C
    J Biol Chem; 2004 Jan; 279(3):1810-8. PubMed ID: 14597630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Kappa Opioid Receptor Inactivation Depends on Sex and Cellular Site of Antagonist Action.
    Reichard KL; Newton KA; Rivera ZMG; Sotero de Menezes PM; Schattauer SS; Land BB; Chavkin C
    Mol Pharmacol; 2020 Nov; 98(5):548-558. PubMed ID: 32913138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. U50488 inhibits HIV-1 expression in acutely infected monocyte-derived macrophages.
    Chao CC; Gekker G; Sheng WS; Hu S; Peterson PK
    Drug Alcohol Depend; 2001 Apr; 62(2):149-54. PubMed ID: 11245971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of κ-opioid receptor signaling in peripheral sensory neurons in vitro and in vivo.
    Berg KA; Rowan MP; Sanchez TA; Silva M; Patwardhan AM; Milam SB; Hargreaves KM; Clarke WP
    J Pharmacol Exp Ther; 2011 Jul; 338(1):92-9. PubMed ID: 21487072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of peripheral kappa opioid receptors inhibits inflammatory hyperalgesia via activation of the PI3Kγ/AKT/nNOS/NO signaling pathway.
    Cunha TM; Souza GR; Domingues AC; Carreira EU; Lotufo CM; Funez MI; Verri WA; Cunha FQ; Ferreira SH
    Mol Pain; 2012 Feb; 8():10. PubMed ID: 22316281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kappa opioid receptors mediate an initial aversive component of paclitaxel-induced neuropathy.
    Meade JA; Alkhlaif Y; Contreras KM; Obeng S; Toma W; Sim-Selley LJ; Selley DE; Damaj MI
    Psychopharmacology (Berl); 2020 Sep; 237(9):2777-2793. PubMed ID: 32529265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
    Zádor F; Lénárt N; Csibrány B; Sántha M; Molnár M; Tuka B; Samavati R; Klivényi P; Vécsei L; Marton A; Vizler C; Nagy GM; Borsodi A; Benyhe S; Páldy E
    Neuropharmacology; 2015 Feb; 89():298-307. PubMed ID: 25446673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.
    Nygard SK; Hourguettes NJ; Sobczak GG; Carlezon WA; Bruchas MR
    J Neurosci; 2016 Sep; 36(38):9937-48. PubMed ID: 27656031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of κ Opioid Receptors in Cutaneous Nerve Endings by Conorphin-1, a Novel Subtype-Selective Conopeptide, Does Not Mediate Peripheral Analgesia.
    Deuis JR; Whately E; Brust A; Inserra MC; Asvadi NH; Lewis RJ; Alewood PF; Cabot PJ; Vetter I
    ACS Chem Neurosci; 2015 Oct; 6(10):1751-8. PubMed ID: 26225903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional selectivity of kappa opioid receptor agonists in peripheral sensory neurons.
    Jamshidi RJ; Jacobs BA; Sullivan LC; Chavera TA; Saylor RM; Prisinzano TE; Clarke WP; Berg KA
    J Pharmacol Exp Ther; 2015 Nov; 355(2):174-82. PubMed ID: 26297384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of 2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a high-affinity antagonist selective for κ-opioid receptors.
    Grimwood S; Lu Y; Schmidt AW; Vanase-Frawley MA; Sawant-Basak A; Miller E; McLean S; Freeman J; Wong S; McLaughlin JP; Verhoest PR
    J Pharmacol Exp Ther; 2011 Nov; 339(2):555-66. PubMed ID: 21821697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal NR2B-containing NMDA receptors enhance long-term potentiation in rats with chronic visceral pain.
    Chen Y; Chen AQ; Luo XQ; Guo LX; Tang Y; Bao CJ; Lin L; Lin C
    Brain Res; 2014 Jun; 1570():43-53. PubMed ID: 24824341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Reduction of Kappa Opioid Receptor Function by the Biased Ligand, Norbinaltorphimine, Requires c-Jun N-Terminal Kinase Activity and New Protein Synthesis in Peripheral Sensory Neurons.
    Jamshidi RJ; Sullivan LC; Jacobs BA; Chavera TA; Berg KA; Clarke WP
    J Pharmacol Exp Ther; 2016 Nov; 359(2):319-328. PubMed ID: 27605628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.